Maryland Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Maryland Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461	Buy	+8	New	+$459	﹤0.01%	289
2024 Q1	–	Sell	-200	Closed	-$10.3K	–	223
2023 Q4	$10.3K	Hold	200	–	–	0.01%	172
2023 Q3	$11.6K	Hold	200	–	–	0.01%	167
2023 Q2	$12.8K	Hold	200	–	–	0.01%	168
2023 Q1	$13.9K	Hold	200	–	–	0.01%	163
2022 Q4	$14.4K	Hold	200	–	–	0.01%	161
2022 Q3	$14K	Hold	200	–	–	0.01%	148
2022 Q2	$15K	Buy	+200	New	+$15.2K	0.02%	147

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Maryland Capital Advisors's BMY Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 8 shares worth $461. The stake represents ﹤0.01% of the portfolio and ranks #289 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in BMY as recently as Q4 2023.

Maryland Capital Advisors first reported a position in BMY in Q2 2022 and has held it in 8 quarters since. The position peaked at $15K in Q2 2022. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Maryland Capital Advisors held 8 shares of Bristol-Myers Squibb worth $461 as of Q2 2026.
Bristol-Myers Squibb was a new Maryland Capital Advisors position in Q2 2026.
Bristol-Myers Squibb made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #289 holding.
Maryland Capital Advisors first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 8 quarters since.
Maryland Capital Advisors's Bristol-Myers Squibb position peaked at $15K in Q2 2022.
2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.